{"transactions":[{"id":2179685,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":124416,"kind":"person","name":"Hallam Thomas","position":1,"cik":"0001850921","reported_name":"Hallam Thomas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series 2 Common Stock Purchase Warrant","published_at":"2022-08-18T21:06:31.000Z","date":"2022-08-16","kind":"purchase","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents Series 2 Common Stock Purchase Warrants received as part of the Units purchased by Reporting Person. The Series 2 Warrants are exercisable upon receipt of stockholder approval per Nasdaq rules, which has not been obtained as of the date of this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents Series 2 Common Stock Purchase Warrants received as part of the Units purchased by Reporting Person. The Series 2 Warrants are exercisable upon receipt of stockholder approval per Nasdaq rules, which has not been obtained as of the date of this Form 4."}],"balance_after":40000,"derivative":{"exercise_price":0.25,"expiration_date":"2027-08-16","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-22-023511","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850921/000149315222023511/ownership.xml","form_type":"4"}},{"id":2179684,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":124416,"kind":"person","name":"Hallam Thomas","position":1,"cik":"0001850921","reported_name":"Hallam Thomas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series 1 Common Stock Purchase Warrant","published_at":"2022-08-18T21:06:31.000Z","date":"2022-08-16","kind":"purchase","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents Series 1 Common Stock Purchase Warrants received as part of the Units purchased by Reporting Person. The Series 1 Warrants are exercisable upon receipt of stockholder approval per Nasdaq rules, which has not been obtained as of the date of this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents Series 1 Common Stock Purchase Warrants received as part of the Units purchased by Reporting Person. The Series 1 Warrants are exercisable upon receipt of stockholder approval per Nasdaq rules, which has not been obtained as of the date of this Form 4."}],"balance_after":40000,"derivative":{"exercise_price":0.25,"expiration_date":"2023-08-16","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-22-023511","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850921/000149315222023511/ownership.xml","form_type":"4"}},{"id":2179683,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":124416,"kind":"person","name":"Hallam Thomas","position":1,"cik":"0001850921","reported_name":"Hallam Thomas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.01","published_at":"2022-08-18T21:06:31.000Z","date":"2022-08-16","kind":"purchase","acquired":true,"shares":40000,"price":0.25,"value":10000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents common shares underlying 40,000 Units of Issuer purchased by Reporting Person (\"Units\") in Underwritten Offering with each Unit containing (i) one share of common stock, (ii) one Series 1 Warrant and (iii) One Series 2 Warrant at a price per Unit of $0.25."}],"balance_after":57592,"source":{"system":"sec-edgar","filing":"0001493152-22-023511","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850921/000149315222023511/ownership.xml","form_type":"4"}},{"id":2315516,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":124416,"kind":"person","name":"Hallam Thomas","position":1,"cik":"0001850921","reported_name":"Hallam Thomas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-03-29T08:37:34.000Z","date":"2022-03-28","kind":"purchase","acquired":true,"shares":10000,"price":1.18,"value":11800.0,"ownership":{"direct":true},"balance_after":17592,"source":{"system":"sec-edgar","filing":"0001209191-22-021405","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850921/000120919122021405/doc4.xml","form_type":"4"}},{"id":2382419,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":124416,"kind":"person","name":"Hallam Thomas","position":1,"cik":"0001850921","reported_name":"Hallam Thomas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-22T17:58:23.000Z","date":"2022-02-17","kind":"grant","acquired":true,"shares":156600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares underlying the Stock Option shall vest and become exercisable on each three-month anniversary of the vesting commencement date and if there is no corresponding day, the last day of the month."}],"balance_after":156600,"derivative":{"exercise_price":0.95,"expiration_date":"2032-02-16","underlying":"Common Stock","underlying_shares":156600},"source":{"system":"sec-edgar","filing":"0001209191-22-011856","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850921/000120919122011856/doc4.xml","form_type":"4"}},{"id":2404511,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":124416,"kind":"person","name":"Hallam Thomas","position":1,"cik":"0001850921","reported_name":"Hallam Thomas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-10T18:36:33.000Z","date":"2021-11-18","kind":"grant","acquired":true,"shares":267868,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares underlying the Stock Option shall vest and become exercisable on each three-month anniversary of the vesting commencement date and if there is no corresponding day, the last day of the month."}],"balance_after":267868,"derivative":{"exercise_price":2.32,"expiration_date":"2031-11-17","underlying":"Common Stock","underlying_shares":267868},"source":{"system":"sec-edgar","filing":"0001209191-22-008592","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850921/000120919122008592/doc4.xml","form_type":"4"}},{"id":2562213,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":124416,"kind":"person","name":"Hallam Thomas","position":1,"cik":"0001850921","reported_name":"Hallam Thomas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-09-22T19:35:08.000Z","date":"2021-09-21","kind":"purchase","acquired":true,"shares":6000,"price":2.49,"value":14940.0,"ownership":{"direct":true},"balance_after":7592,"source":{"system":"sec-edgar","filing":"0001209191-21-057318","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850921/000120919121057318/doc4.xml","form_type":"4"}},{"id":2736018,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":124416,"kind":"person","name":"Hallam Thomas","position":1,"cik":"0001850921","reported_name":"Hallam Thomas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-29T17:52:52.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":27190,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F20","text":"Received in the Merger in exchange for a stock option to acquire 1,000,000 shares of LBS common stock for $0.48 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The stock option is fully vested."}],"balance_after":27190,"derivative":{"exercise_price":17.72,"expiration_date":"2031-04-26","underlying":"Common Stock","underlying_shares":27190},"source":{"system":"sec-edgar","filing":"0001209191-21-029076","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1850921/000120919121029076/doc4.xml","form_type":"4"}},{"id":2736017,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":124416,"kind":"person","name":"Hallam Thomas","position":1,"cik":"0001850921","reported_name":"Hallam Thomas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-29T17:52:52.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":12294,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F19","text":"Received in the Merger in exchange for a stock option to acquire 452,200 shares of LBS common stock for $0.73 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests in 12 equal quarterly installments from the vesting commencement date."}],"balance_after":12294,"derivative":{"exercise_price":26.85,"expiration_date":"2030-02-19","underlying":"Common Stock","underlying_shares":12294},"source":{"system":"sec-edgar","filing":"0001209191-21-029076","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1850921/000120919121029076/doc4.xml","form_type":"4"}},{"id":2736016,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":124416,"kind":"person","name":"Hallam Thomas","position":1,"cik":"0001850921","reported_name":"Hallam Thomas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-29T17:52:52.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":15002,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F18","text":"Received in the Merger in exchange for a stock option to acquire 551,753 shares of LBS common stock for $1.45 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F17","text":"The stock option vests according to the following schedule: 67% of the shares underlying the option vests on the grant date and the remaining 33% vests in four equal quarterly installments thereafter beginning on March 31, 2019."}],"balance_after":15002,"derivative":{"exercise_price":53.33,"expiration_date":"2029-03-22","underlying":"Common Stock","underlying_shares":15002},"source":{"system":"sec-edgar","filing":"0001209191-21-029076","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1850921/000120919121029076/doc4.xml","form_type":"4"}},{"id":2736015,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":124416,"kind":"person","name":"Hallam Thomas","position":1,"cik":"0001850921","reported_name":"Hallam Thomas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-29T17:52:52.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":20392,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F16","text":"Received in the Merger in exchange for a stock option to acquire 750,000 shares of LBS common stock for $1.12 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The stock option is fully vested."}],"balance_after":20392,"derivative":{"exercise_price":41.2,"expiration_date":"2029-03-22","underlying":"Common Stock","underlying_shares":20392},"source":{"system":"sec-edgar","filing":"0001209191-21-029076","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1850921/000120919121029076/doc4.xml","form_type":"4"}},{"id":2736014,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":124416,"kind":"person","name":"Hallam Thomas","position":1,"cik":"0001850921","reported_name":"Hallam Thomas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-29T17:52:52.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":8754,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F15","text":"Received in the Merger in exchange for a stock option to acquire 322,000 shares of LBS common stock for $1.12 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests in 12 equal quarterly installments from the vesting commencement date."}],"balance_after":8754,"derivative":{"exercise_price":41.2,"expiration_date":"2029-03-22","underlying":"Common Stock","underlying_shares":8754},"source":{"system":"sec-edgar","filing":"0001209191-21-029076","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1850921/000120919121029076/doc4.xml","form_type":"4"}},{"id":2736013,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":124416,"kind":"person","name":"Hallam Thomas","position":1,"cik":"0001850921","reported_name":"Hallam Thomas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-29T17:52:52.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":22730,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F14","text":"Received in the Merger in exchange for a stock option to acquire 836,000 shares of LBS common stock for $1.12 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"The stock option vests according to the following schedule: 67% of the shares underlying the option vests on the grant date and the remaining 33% vests in eight equal quarterly installments thereafter beginning on March 31, 2019."}],"balance_after":22730,"derivative":{"exercise_price":41.2,"expiration_date":"2029-03-22","underlying":"Common Stock","underlying_shares":22730},"source":{"system":"sec-edgar","filing":"0001209191-21-029076","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1850921/000120919121029076/doc4.xml","form_type":"4"}},{"id":2736012,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":124416,"kind":"person","name":"Hallam Thomas","position":1,"cik":"0001850921","reported_name":"Hallam Thomas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-29T17:52:52.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":95572,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Received in the Merger in exchange for a stock option to acquire 3,515,000 shares of LBS common stock for $0.75 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The stock option vests according to the following schedule: 25% of the shares underlying the option vests on grant date and the remaining 75% vests in nine equal quarterly installments thereafter beginning on January 1, 2018."}],"balance_after":95572,"derivative":{"exercise_price":27.59,"expiration_date":"2027-11-10","underlying":"Common Stock","underlying_shares":95572},"source":{"system":"sec-edgar","filing":"0001209191-21-029076","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1850921/000120919121029076/doc4.xml","form_type":"4"}},{"id":2736011,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":124416,"kind":"person","name":"Hallam Thomas","position":1,"cik":"0001850921","reported_name":"Hallam Thomas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-29T17:52:52.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":2719,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Received in the Merger in exchange for a stock option to acquire 100,000 shares of LBS common stock for $0.75 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The stock option is fully vested."}],"balance_after":2719,"derivative":{"exercise_price":27.59,"expiration_date":"2027-11-10","underlying":"Common Stock","underlying_shares":2719},"source":{"system":"sec-edgar","filing":"0001209191-21-029076","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1850921/000120919121029076/doc4.xml","form_type":"4"}},{"id":2736010,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":124416,"kind":"person","name":"Hallam Thomas","position":1,"cik":"0001850921","reported_name":"Hallam Thomas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-29T17:52:52.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":477,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Received in the Merger in exchange for a stock option to acquire 17,567 shares of LBS common stock for $0.75 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The stock option is fully vested."}],"balance_after":477,"derivative":{"exercise_price":27.59,"expiration_date":"2024-02-02","underlying":"Common Stock","underlying_shares":477},"source":{"system":"sec-edgar","filing":"0001209191-21-029076","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1850921/000120919121029076/doc4.xml","form_type":"4"}},{"id":2736009,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":124416,"kind":"person","name":"Hallam Thomas","position":1,"cik":"0001850921","reported_name":"Hallam Thomas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-29T17:52:52.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":6797,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Received in the Merger in exchange for a stock option to acquire 250,000 shares of LBS common stock for $0.75 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests in 12 equal quarterly installments from the vesting commencement date."}],"balance_after":6797,"derivative":{"exercise_price":27.59,"expiration_date":"2025-02-02","underlying":"Common Stock","underlying_shares":6797},"source":{"system":"sec-edgar","filing":"0001209191-21-029076","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1850921/000120919121029076/doc4.xml","form_type":"4"}},{"id":2736008,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":124416,"kind":"person","name":"Hallam Thomas","position":1,"cik":"0001850921","reported_name":"Hallam Thomas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-29T17:52:52.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":27189,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Received in the Merger in exchange for a stock option to acquire 1,000,000 shares of LBS common stock for $0.50 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested according to the following schedule: 17% of the shares underlying the option vested on grant date and the remaining 83% vested in 10 equal quarterly installments thereafter beginning on June 30, 2014."}],"balance_after":27189,"derivative":{"exercise_price":18.39,"expiration_date":"2023-10-01","underlying":"Common Stock","underlying_shares":27189},"source":{"system":"sec-edgar","filing":"0001209191-21-029076","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1850921/000120919121029076/doc4.xml","form_type":"4"}},{"id":2736007,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":124416,"kind":"person","name":"Hallam Thomas","position":1,"cik":"0001850921","reported_name":"Hallam Thomas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-29T17:52:52.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":4078,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received in the Merger in exchange for a stock option to acquire 150,000 shares of LBS common stock for $0.40 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested according to the following schedule: 50% of the shares underlying the option vested on the grant date and the remaining 50% vested in six equal quarterly installments thereafter beginning on July 9, 2014."}],"balance_after":4078,"derivative":{"exercise_price":14.72,"expiration_date":"2022-10-10","underlying":"Common Stock","underlying_shares":4078},"source":{"system":"sec-edgar","filing":"0001209191-21-029076","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1850921/000120919121029076/doc4.xml","form_type":"4"}},{"id":2736006,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":124416,"kind":"person","name":"Hallam Thomas","position":1,"cik":"0001850921","reported_name":"Hallam Thomas","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-04-29T17:52:52.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":1592,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired the shares of the Issuer in exchange for 58,582 shares of common stock of Leading BioSciences, Inc. (\"LBS\"), pursuant to the Agreement and Plan of Merger, dated December 16, 2020, among Seneca Biopharma Inc., Townsgate Acquisition Sub 1, Inc. and LBS (the \"Merger\").  Per the terms of the Merger, each share of LBS's common stock was converted into the right to receive 0.02719 shares of Seneca's common stock.  In the Merger, the name of the Issuer was changed from Seneca Biopharma, Inc. to Palisade Bio, Inc."}],"balance_after":1592,"source":{"system":"sec-edgar","filing":"0001209191-21-029076","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850921/000120919121029076/doc4.xml","form_type":"4"}}]}